Xeris Biopharma (XERS) Operating Margin (2020 - 2026)
Xeris Biopharma (XERS) operating margin from Sep 30, 2020 to Mar 31, 2026. The current Xeris Biopharma (XERS) operating margin is 9.53%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Xeris Biopharma (XERS)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 8.53% | -151.49% |
| 2024 | -16.57% | -38.28% |
| 2023 | -26.85% | -63.87% |
| 2022 | -74.32% | -68.00% |
| 2021 | -232.22% | -43.97% |
| 2020 | -414.43% | N/A |
Comparison Xeris Biopharma (XERS) operating margin with competitors
Xeris Biopharma (XERS) operating margin is 9.53%.